CAS: 77-38-3 - chlorphenoxamine
Formula:C18H22ClNO
InChI:InChI=1S/C18H22ClNO/c1-18(21-14-13-20(2)3,15-7-5-4-6-8-15)16-9-11-17(19)12-10-16/h4-12H,13-14H2,1-3H3
InChI key:InChIKey=KKHPNPMTPORSQE-UHFFFAOYSA-N
SMILES:ClC1=CC=C(C=C1)C(OCCN(C)C)(C=2C=CC=CC2)C
- Synonyms:
- 2-(p-Chloro-α-methyl-α-phenylbenzyloxy)-N,N-dimethylethylamine
- 2-[1-(4-chlorophenyl)-1-phenylethoxy]-N,N-dimethylethanamine
- Ethanamine, 2-[1-(4-chlorophenyl)-1-phenylethoxy]-N,N-dimethyl-
- Ethylamine, 2-[(p-chloro-α-methyl-α-phenylbenzyl)oxy]-N,N-dimethyl-
- N-(2-(1-p-chlorophenyl-1-phenylethoxy)ethyl)dimethylamine
- [1-(p-Chlorophenyl)-1-phenylethyl] (β-dimethylaminoethyl) ether
- p-Chloro-α-methyldiphenhydramine
- β-Dimethylaminoethyl (p-chloro-α-methylbenzhydryl) ether
Chlorphenoxamine
CAS:77-38-3
Formula:
C18H22ClNO
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
303.8264
Ref: IN-DA005N00
50mg | 146.00 € | ||
100mg | 195.00 € | ||
250mg | 558.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
Chlorphenoxamine
CAS:77-38-3
Chlorphenoxamine (Contristamine) is an antihistamine and anticholinergic used as an antipruritic and antiparkinsonian agent.
Formula:
C18H22ClNO
Purity:
99.44%
Color and Shape:
Solid
Molecular weight:
303.83
Ref: TM-T7564
5mg | 51.00 € | ||
10mg | 80.00 € | ||
50mg | 145.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: TR-C179005
10mg | 94.00 € | ||
50mg | 134.00 € | ||
100mg | 195.00 € |
Estimated delivery in United States, on Thursday 12 Dec 2024
Ref: 10-F064585
1g | To inquire | ||
50mg | To inquire | ||
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Thursday 12 Dec 2024
Chlorphenoxamine
Controlled ProductCAS:77-38-3
Chlorphenoxamine is an analog of flupirtine that is used as a pharmaceutical drug. Chlorphenoxamine has …
Formula:
C18H22ClNO
Purity:
Min. 95%
Molecular weight:
303.83 g/mol
Ref: 3D-AAA07738
10mg | 172.00 € | ||
25mg | 248.00 € | ||
50mg | 364.00 € | ||
100mg | 517.00 € | ||
250mg | 924.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025